Skip to content

Advertisement

Translational Neurodegeneration

What do you think about BMC? Take part in

Featured article: Current understanding of the molecular mechanisms in Parkinson's disease

New Content ItemThis review provides basic conceptual information on the molecular mechanisms underlying Parkinson’s Disease, which may assist in the design of more effective drugs or other treatment strategies.

Read the article

Articles

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Journal news

Translational Neurodegeneration has been accepted into the Science Citation Index Expanded (SCIE), Web of Science.

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

Article-processing charges

The publication costs for Translational Neurodegeneration are covered by Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China, so authors do not need to pay an article-processing charge for each article accepted for publication.

Advertisement

Affiliated with

  • Ruijin hospital_2

2016 Journal Metrics

Advertisement